Article
Exploring targeted therapy in retinal vasculopathy with cerebral leukoencephalopathy: a case report and review of literature.
Frontiers in immunology - 1 Jan 2025
Tato-Moreno Patricia, Lavilla Olleros Cristina, Balastegui Martín Héctor, Barrientos Guerrero María, Mensa-Vilaro Anna, Durán-García María Esther, Sánchez-Mateos Paloma, García-Martínez Elena
Abstract excerpt
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S) is a rare autosomal dominant microvascular disorder caused by C-terminal truncating mutations in TREX1 gene, which impair protein localization and lead to multisystem involvement. We report a patient carrying the pathogenic TREX1 variant NM_033629.6:c.703dup (p.Val235fs), the most frequently described mutation in RVCL-S,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
